DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA

Lobbying client · New York · filed 2025 to 2026

Non-profit product development partnership

$60,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (50753), not by name.

Firms hired 1

VENABLE LLP $60,000 6 filings

Reported by year 2 years

2026 $20,000 2 filings
2025 $40,000 4 filings

Issues lobbied 1

Budget/Appropriations 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

SENATE 3
HOUSE OF REPRESENTATIVES 1

Recent filings 6 total

Q2

VENABLE LLP

2nd Quarter (Apr 1 - June 30) 2026 · Senate · $10,000 income · posted Jul 20, 2026

View → Q1

VENABLE LLP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted Apr 14, 2026

View → Q4

VENABLE LLP

4th Quarter (Oct 1 - Dec 31) 2025 · $10,000 income · posted Jan 5, 2026

View → Q3

VENABLE LLP

3rd Quarter (July 1 - Sep 30) 2025 · $10,000 income · posted Oct 14, 2025

View → Q2

VENABLE LLP

2nd Quarter (Apr 1 - June 30) 2025 · $10,000 income · posted Jul 9, 2025

View → Q1

VENABLE LLP

1st Quarter (Jan 1 - Mar 31) 2025 · Senate · $10,000 income · posted Apr 11, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.